CHEBI:65629 - 16β-[(O-(2-O-(E)-cinnamoyl-β-D-xylopyranosyl)-(1→2)-2-O-acetyl-α-L-arabinopyranosyl)oxy]-3β-[(β-D-glucopyranosyl)oxy]-17α-hydroxycholest-5-en-22-one

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name 16β-[(O-(2-O-(E)-cinnamoyl-β-D-xylopyranosyl)-(1→2)-2-O-acetyl-α-L-arabinopyranosyl)oxy]-3β-[(β-D-glucopyranosyl)oxy]-17α-hydroxycholest-5-en-22-one
ChEBI ID CHEBI:65629
ChEBI ASCII Name 16beta-[(O-(2-O-(E)-cinnamoyl-beta-D-xylopyranosyl)-(1->2)-2-O-acetyl-alpha-L-arabinopyranosyl)oxy]-3beta-[(beta-D-glucopyranosyl)oxy]-17alpha-hydroxycholest-5-en-22-one
Definition A steroid saponin isolated from Ornithogalum saundersiae and Galtonia candicans and has been shown to exhibit cytotoxic activity.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Formula C54H78O19
Net Charge 0
Average Mass 1031.18570
Monoisotopic Mass 1030.51373
InChI InChI=1S/C54H78O19/c1-27(2)12-16-36(57)28(3)54(65)40(23-35-33-15-14-31-22-32(18-20-52(31,5)34(33)19-21-53(35,54)6)69-49-45(64)44(63)43(62)39(24-55)70-49)71-51-48(68-29(4)56)46(38(59)26-67-51)73-50-47(42(61)37(58)25-66-50)72-41(60)17-13-30-10-8-7-9-11-30/h7-11,13-14,17,27-28,32-35,37-40,42-51,55,58-59,61-65H,12,15-16,18-26H2,1-6H3/b17-13+/t28-,32-,33+,34-,35-,37+,38-,39+,40-,42-,43+,44-,45+,46-,47+,48+,49+,50-,51-,52-,53-,54+/m0/s1
InChIKey XPJVFNVOMZCPBQ-QLOXOBCISA-N
SMILES [H][C@@]12CC=C3C[C@H](CC[C@]3(C)[C@@]1([H])CC[C@@]1(C)[C@@]2([H])C[C@H](O[C@@H]2OC[C@H](O)[C@H](O[C@@H]3OC[C@@H](O)[C@H](O)[C@H]3OC(=O)\C=C\c3ccccc3)[C@H]2OC(C)=O)[C@]1(O)[C@@H](C)C(=O)CCC(C)C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
Metabolite of Species Details
Ornithogalum saundersiae (NCBI:txid484171) Found in bulb (BTO:0000159). See: DOI
Galtonia candicans (NCBI:txid81751) Found in bulb (BTO:0000159). See: PubMed
Roles Classification
Biological Role(s): metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via 16beta-[(O-(2-O-(E)-cinnamoyl-beta-D-xylopyranosyl)-(1->2)-2-O-acetyl-alpha-L-arabinopyranosyl)oxy]-3beta-[(beta-D-glucopyranosyl)oxy]-17alpha-hydroxycholest-5-en-22-one )
Application(s): antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
(via 16beta-[(O-(2-O-(E)-cinnamoyl-beta-D-xylopyranosyl)-(1->2)-2-O-acetyl-alpha-L-arabinopyranosyl)oxy]-3beta-[(beta-D-glucopyranosyl)oxy]-17alpha-hydroxycholest-5-en-22-one )
View more via ChEBI Ontology
ChEBI Ontology
Outgoing 16β-[(O-(2-O-(E)-cinnamoyl-β-D-xylopyranosyl)-(1→2)-2-O-acetyl-α-L-arabinopyranosyl)oxy]-3β-[(β-D-glucopyranosyl)oxy]-17α-hydroxycholest-5-en-22-one (CHEBI:65629) has functional parent trans-cinnamic acid (CHEBI:35697)
16β-[(O-(2-O-(E)-cinnamoyl-β-D-xylopyranosyl)-(1→2)-2-O-acetyl-α-L-arabinopyranosyl)oxy]-3β-[(β-D-glucopyranosyl)oxy]-17α-hydroxycholest-5-en-22-one (CHEBI:65629) has role antineoplastic agent (CHEBI:35610)
16β-[(O-(2-O-(E)-cinnamoyl-β-D-xylopyranosyl)-(1→2)-2-O-acetyl-α-L-arabinopyranosyl)oxy]-3β-[(β-D-glucopyranosyl)oxy]-17α-hydroxycholest-5-en-22-one (CHEBI:65629) has role metabolite (CHEBI:25212)
16β-[(O-(2-O-(E)-cinnamoyl-β-D-xylopyranosyl)-(1→2)-2-O-acetyl-α-L-arabinopyranosyl)oxy]-3β-[(β-D-glucopyranosyl)oxy]-17α-hydroxycholest-5-en-22-one (CHEBI:65629) is a β-D-glucoside (CHEBI:22798)
16β-[(O-(2-O-(E)-cinnamoyl-β-D-xylopyranosyl)-(1→2)-2-O-acetyl-α-L-arabinopyranosyl)oxy]-3β-[(β-D-glucopyranosyl)oxy]-17α-hydroxycholest-5-en-22-one (CHEBI:65629) is a 17-hydroxy steroid (CHEBI:36838)
16β-[(O-(2-O-(E)-cinnamoyl-β-D-xylopyranosyl)-(1→2)-2-O-acetyl-α-L-arabinopyranosyl)oxy]-3β-[(β-D-glucopyranosyl)oxy]-17α-hydroxycholest-5-en-22-one (CHEBI:65629) is a acetate ester (CHEBI:47622)
16β-[(O-(2-O-(E)-cinnamoyl-β-D-xylopyranosyl)-(1→2)-2-O-acetyl-α-L-arabinopyranosyl)oxy]-3β-[(β-D-glucopyranosyl)oxy]-17α-hydroxycholest-5-en-22-one (CHEBI:65629) is a cinnamate ester (CHEBI:36087)
IUPAC Name
(3β,16β,20R)-16-[(2-O-acetyl-3-O-{2-O-[(2E)-3-phenylprop-2-enoyl]-β-D-xylopyranosyl}-α-L-arabinopyranosyl)oxy]-17-hydroxy-22-oxocholest-5-en-3-yl β-D-glucopyranoside
Citation Waiting for Citations Type Source
11515577 PubMed citation Europe PMC
Last Modified
31 July 2013